Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
- Author:
Tomoyuki KAWADA
1
Author Information
- Publication Type:Letter
- From:Diabetes & Metabolism Journal 2022;46(4):663-664
- CountryRepublic of Korea
- Language:English
